The Cigna Group (CI) Earnings Call Transcripts

The Cigna Group's Latest Earnings Call - Q2 FY2026

In the second quarter of 2026, The Cigna Group reported total revenues of $71.7 billion and adjusted earnings per share (EPS) of $7.78, both exceeding expectations. Management raised their full-year adjusted EPS guidance to at least $30.45, reflecting strong performance across both Evernorth and Cigna Healthcare. Key drivers of growth included a 6% year-over-year revenue increase in Evernorth and a 10% rise in Cigna Healthcare, with notable contributions from specialty services and pharmacy benefit innovations.

Reported metrics

Guidance from management

Management raised the full-year adjusted EPS guidance to at least $30.45, reflecting confidence from strong Q2 performance while maintaining a prudent view of the current environment.

What management said

Yes, sure. So A.J., the release of the 2025 final risk adjustment data and also the June weekly update for 2026 confirmed our risk adjustment position, so results were consistent with our expectations, and it wasn't a driver for the quarter.

Just to simplify This down a bit as you think about what happened in the second quarter versus the full year, we had strength in the second quarter above expectations for Evernorth. We're anticipating a little bit of modest downward pressure on the GLP-1 volumes for the back half of the year. So essentially, the outperformance in the second quarter is given back in the form of slightly lower GLP-1 volumes in the back...

What analysts pressed on

Analysts expressed concerns regarding the impact of GLP-1 drug coverage changes on future growth, as Cigna has ended coverage for weight management. Additionally, there were questions about the transition to the new Pharmacy Benefit Services model and its implications for profitability and client retention.

Main topics on the call

• Revenue Growth Across Segments — The Cigna Group achieved total revenues of $71.7 billion in Q2 2026, with Evernorth revenues growing 6% year-over-year and Cigna Healthcare revenues increasing by 10%. Management noted, "both Evernorth and Cigna Healthca...
• Increased Guidance — Management raised the full-year adjusted EPS guidance to at least $30.45, up from previous estimates, citing strong first-half performance. Ann Dennison stated, "we are pleased to increase our full year 2026 adjusted ear...
• Specialty & Care Services Performance — Earnings from Specialty & Care Services grew 22% year-over-year, driven by increased specialty utilization and adoption of biosimilars. Ann Dennison noted, "the sustained growth in our Specialty & Care Services business ...
• Pharmacy Benefit Services Transition — Earnings from Pharmacy Benefit Services were $609 million, reflecting the transition to a new rebate-free model. Management indicated strong interest from health plans and employers in the upcoming Signature model, expec...

Read the full The Cigna Group transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 68 The Cigna Group earnings call transcripts on record, spanning January 14, 2020 to July 30, 2026. Based on this history, The Cigna Group reports quarterly. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

CI

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

68

First call

January 14, 2020

Most recent

July 30, 2026

Reporting cadence

quarterly